Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Singapore Continues To Attract MNCs; Hill-Rom The Latest To Open Innovation Center In Country

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Worldwide medical technology and device maker Hill-Rom opened its Asia-Pacific Innovation Center in Singapore Aug. 24. The new center will focus on research and development in micro-electronics and embedded software

You may also be interested in...



Singapore's National University Hospital Establishes New Clinical Trial Unit For Early-Phase Trials For Novel Therapies

SINGAPORE - Singapore's National University Health System has established an investigational medicine unit within the National University Hospital to conduct more complex early-phase clinical trials across medical disciplines

Singapore's National University Hospital Establishes New Clinical Trial Unit For Early-Phase Trials For Novel Therapies

SINGAPORE - Singapore's National University Health System has established an investigational medicine unit within the National University Hospital to conduct more complex early-phase clinical trials across medical disciplines

Singapore's Medical Device Market Growing Strong; $2.1 Billion In 2008

SINGAPORE - Singapore's medical device sector recorded S$3 billion ($2.1 billion) in manufacturing output and employed 8,200 workers in 2008, and the sector is expected to continue growing at a healthy rate

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC069758

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel